Physician profile
Egle Bavry
NPI 1851369623
$3,173.96
in general payments reported to CMS, 2019-2025
12 companies · $812 in 2025
The $812 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10.73 · 2021: $392 · 2022: $881 · 2023: $510 · 2024: $569 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $843.63 | 2021-2025 | Intellis Adaptivestim, Osteocool Rf Ablation System, Inceptiv |
| Boston Scientific Corporation | $654.46 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Spr Therapeutics, INC | $375.19 | 2020-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $360.90 | 2022-2023 | Intracept |
| Nevro Corp. | $308.13 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $178.50 | 2023-2025 | Evoke, Evoke Scs |
| Mml US, INC. | $124.97 | 2025 | Reactiv8 |
| Globus Medical, INC. | $120.24 | 2025 | Senza |
| Abbott Laboratories | $89.63 | 2021-2025 | Eterna |
| Nalu Medical, INC. | $59.29 | 2022 | |
| Hydrocision, INC. | $34.51 | 2025 | Tenjet |
| Si-Bone, INC. | $24.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Egle Bavry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.